Moneycontrol PRO

Bafna Pharma Standalone December 2021 Net Sales at Rs 20.46 crore, up 17.08% Y-o-Y

February 11, 2022 / 01:33 PM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Reported Standalone quarterly numbers for Bafna Pharmaceuticals are:

Net Sales at Rs 20.46 crore in December 2021 up 17.08% from Rs. 17.48 crore in December 2020.

Quarterly Net Profit at Rs. 1.70 crore in December 2021 up 89.12% from Rs. 0.90 crore in December 2020.

EBITDA stands at Rs. 3.32 crore in December 2021 up 47.56% from Rs. 2.25 crore in December 2020.

Bafna Pharma EPS has increased to Rs. 0.72 in December 2021 from Rs. 0.38 in December 2020.

Close

Bafna Pharma shares closed at 177.65 on February 10, 2022 (NSE) and has given 22.94% returns over the last 6 months and 57.07% over the last 12 months.

Bafna Pharmaceuticals
Standalone Quarterly Resultsin Rs. Cr.
Dec'21Sep'21Dec'20
Net Sales/Income from operations20.4628.4417.48
Other Operating Income------
Total Income From Operations20.4628.4417.48
EXPENDITURE
Consumption of Raw Materials10.3018.4211.15
Purchase of Traded Goods------
Increase/Decrease in Stocks2.08-2.240.04
Power & Fuel------
Employees Cost3.633.903.25
Depreciation1.211.421.02
Excise Duty------
Admin. And Selling Expenses------
R & D Expenses------
Provisions And Contingencies------
Exp. Capitalised------
Other Expenses1.612.660.83
P/L Before Other Inc. , Int., Excpt. Items & Tax1.634.271.19
Other Income0.490.180.04
P/L Before Int., Excpt. Items & Tax2.114.451.23
Interest0.410.110.33
P/L Before Exceptional Items & Tax1.704.340.90
Exceptional Items---1.97--
P/L Before Tax1.702.380.90
Tax------
P/L After Tax from Ordinary Activities1.702.380.90
Prior Year Adjustments------
Extra Ordinary Items------
Net Profit/(Loss) For the Period1.702.380.90
Equity Share Capital23.6623.6623.66
Reserves Excluding Revaluation Reserves------
Equity Dividend Rate (%)------
EPS Before Extra Ordinary
Basic EPS0.720.950.38
Diluted EPS0.720.950.38
EPS After Extra Ordinary
Basic EPS0.720.950.38
Diluted EPS0.720.950.38
Public Share Holding
No Of Shares (Crores)------
Share Holding (%)------
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores)------
- Per. of shares (as a % of the total sh. of prom. and promoter group)------
- Per. of shares (as a % of the total Share Cap. of the company)------
b) Non-encumbered
- Number of shares (Crores)------
- Per. of shares (as a % of the total sh. of prom. and promoter group)------
- Per. of shares (as a % of the total Share Cap. of the company)------
Source : Dion Global Solutions Limited

Sections
ISO 27001 - BSI Assurance Mark